轻度哮喘持续患儿血清镁水平与症状控制及肺功能关系的研究
作者:
作者单位:

绵阳市中心医院 儿科, 四川 绵阳 621099

通讯作者:

胡煜,E-mail:976700544@qq.com

中图分类号:

R725.6


Relationship between serum magnesium level and lung function in children with mild asthma
Author:
Affiliation:

Department of Pediatrics, Mianyang Central Hospital, Mianyang, Sichuan 621099, China

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [24]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    目的 探讨轻度哮喘持续患儿血清镁水平与症状控制及肺功能的关系。方法 选取2017年1月—2019年12月绵阳市中心医院收治的320例轻度哮喘持续患儿为研究对象。所有患儿均行肺功能检测,入院后完成血清镁水平检测。采用儿童哮喘控制测试问卷(ACT)进行症状控制评估。根据ACT评分将患儿分为控制良好组、部分控制组及未控制组。分析比较症状控制不同患儿肺功能、血清镁水平的差异。结果 全组患儿血清镁水平为1.5~2.5 mg/dL,低镁血症的患病率为5.31%(17/320)。不同哮喘控制组的第1秒钟用力呼气容积占用力肺活量比值(FEV1/FVC)、FEV1%预测值、呼气流速峰值(PEFR)及ACT评分比较,差异有统计学意义(P <0.05),控制良好组高于部分控制组和未控制组(P <0.05)。多因素Logistic回归分析结果显示,留守儿童[O^R=2.065(95% CI:1.119,3.974)]、家族史[O^R=2.317(95% CI:1.214,4.482)]、病程[O^R=2.353(95% CI:1.329,5.215)]、治疗时间[O^R=2.147(95% CI:1.032,4.978)]、合并过敏性鼻炎[O^R=2.587(95% CI:0.214,3.365)]、治疗依从性[O^R=1.934(95% CI:1.021,3.368)]是影响哮喘患儿病情控制的独立危险因素(P <0.05)。Spearman相关性分析结果显示,ACT评分与FEV1、PEFR呈正相关(rs =0.399和0.246,均P <0.05)。血清镁水平与ACT评分、FEV1、PEFR无相关(P >0.05),与治疗时间呈负相关(rs =-0.162,P <0.05)。结论 轻度哮喘持续患儿存在一定的低镁血症发生率,但血清镁水平与哮喘症状控制之间没有相关性。

    Abstract:

    Objective To investigate the relationship between serum magnesium level and pulmonary function in children with mild asthma.Methods A total of 320 children with mild asthma were selected as the study object. All the children were tested for lung function and serum magnesium level after admission. Symptom control was performed with the child asthma control test questionnaire (ACT). According to the ACT score, the children were divided into well controlled group, partial control group, and uncontrolled group. The differences of pulmonary function and serum magnesium level in children with different symptom control levels were analyzed and compared.Results The total serum magnesium level range was 1.5 to 2.5 mg/dL, and the prevalence of hypomagnesemia was 5.31% (17/320). The ratio of forced expiratory volume in forced vital capacity (FEV1 / FVC), predicted value of FEV1%, peak expiratory flow rate (PEFR), and act score in the first second in different asthma control groups were significantly different (P < 0.05), and those in the well controlled group were higher than those in partial control groups and uncontrolled groups (P < 0.05). Multivariate logistic regression analysis showed whether it was left behind children [O^R = 2.065 (95% CI: 1.119, 3.974) ], whether it had family history [O^R = 2.317 (95% CI: 1.214, 4.482) ], duration of disease [O^R = 2.353 (95% CI: 1.329, 5.215) ], treatment time [O^R = 2.147 (95% CI: 1.032, 4.978) ], whether it was complicated with allergic rhinitis [O^R = 2.587 (95% CI: 0.214, 3.365) ], and treatment compliance [O^R = 1.934 (95% CI: 1.021, 3.368) ] were independent risk factors affecting the control level of children with asthma (P < 0.05). Spearman correlation analysis showed that ACT score was positively correlated with FEV1 and PEFR (rs = 0.399 and 0.246, all P < 0.05). Serum magnesium level was not correlated with ACT score, FEV1, and PEFR (P > 0.05), but negatively correlated with treatment time (rs = -0.162, P < 0.05).Conclusion There is a certain incidence of hypomagnesemia in mild persistent children, but there is no significant correlation between serum magnesium level and asthma symptom control.

    参考文献
    [1] SONG X L, XIE S S, LU K, et al. Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages[J]. Inflammation, 2015, 38(2): 485-492.
    [2] 黄梦嘉, 张静波, 刘杰, 等. 职业性哮喘患者直接经济负担分析[J]. 中华劳动卫生职业病杂志, 2020, 38(6): 437-440.
    [3] O'BYRNE PM, METEV H, PUU M, et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial[J]. Lancet Respir Med, 2016, 4(10): 797-806.
    [4] CHITAMANNI P, CHANDRASEKARAN V, RAJENDIRAN S. Serum total magnesium level and its correlation with symptom control in children with mild persistent asthma[J]. Indian J Pediatr, 2018, 85(6): 420-425.
    [5] TANQUEREL L, FILLION-BERTRAND G, LAVOIE J P, et al. Effects of magnesium sulfate infusion on clinical signs and lung function of horses with severe asthma[J]. Am J Vet Res, 2018, 79(6): 664-673.
    [6] KAZAKS A G, STERN J S. Overweight and obesity are associated with decreased magnesium intake in people with asthma[J]. Calif Agric (Berkeley), 2007, 61(3): 119-123.
    [7] MATHEW J L, WALIA M. Systematic review on efficacy of magnesium (intravenous or nebulized) for acute asthma episodes in children[J]. Indian Pediatr, 2017, 54(2): 133-137.
    [8] 陈宝生, 张振, 莫耀南, 等. 镁离子在支气管哮喘气道重塑中的作用研究[J]. 陕西医学杂志, 2010, 39(8): 967-969.
    [9] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J]. 中华内科杂志, 2003, 42(11): 817-822.
    [10] PéREZ-YARZA E G, CASTRO-RODRIGUEZ J A, VILLA ASENSI J R, et al. Validation of a Spanish version of the childhood asthma control test (SC-ACT) for use in Spain[J]. An Pediatr (Barc), 2015, 83(2): 94-103.
    [11] SEIN H H, WHYE LIAN C, JUAN LOONG K, et al. Relationship between intracellular magnesium level, lung function, and level of asthma control in children with chronic bronchial asthma[J]. Malays J Med Sci, 2014, 21(5): 30-36.
    [12] SHAABAN R, ZUREIK M, SOUSSAN D, et al. Rhinitis and onset of asthma: a longitudinal population-based study[J], Lancet, 2008, 372(9643): 1049-1057.
    [13] HARRINGTON C B, LANGHANS E, SHELEF D Q, et al. A pilot randomized trial of school-based administration of inhaled corticosteroids for at-risk children with asthma[J]. J Asthma, 2018, 55(2): 145-151.
    [14] LENNEY W, BUSH A, FITZGERALD D A, et al. Improving the global diagnosis and management of asthma in children[J]. Thorax, 2018, 73(7): 662-669.
    [15] EGAN M, BUNYAVANICH S. Allergic rhinitis: the "Ghost Diagnosis" in patients with asthma[J]. Asthma Res Pract, 2015, 1: 8.
    [16] KAZAKS A G, URIU-ADAMS J Y, ALBERTSON T E, et al. Multiple measures of magnesium status are comparable in mild asthma and control subjects[J]. J Asthma, 2006, 43(10): 783-788.
    [17] WANG J L, SHAW N S, KAO M D. Magnesium deficiency and its lack of association with asthma in taiwanese elementary school children[J]. Asia Pac J Clin Nutr, 2007, 16 Suppl 2:579-584.
    [18] DAS S K, HALDAR A K, GHOSH I, et al. Serum magnesium and stable asthma: is there a link[J]. Lung India, 2010, 27(4): 205-208.
    [19] ALAMOUDI O S. Hypomagnesaemia in chronic, stable asthmatics: prevalence, correlation with severity and hospitalization[J]. Eur Respir J, 2000, 16(3): 427-431.
    [20] AMIN M, ABDEL-FATTAH M, ZAGHLOUL S S. Magnesium concentration in acute asthmatic children[J]. Iran J Pediatr, 2012, 22(4): 463-467.
    [21] GILLILAND F D, BERHANE K T, LI Y F, et al. Dietary magnesium, potassium, sodium, and children's lung function[J]. Am J Epidemiol, 2002, 155(2): 125-131.
    [22] GONTIJO-AMARAL C, RIBEIRO M A, GONTIJO L S, et al. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial[J]. Eur J Clin Nutr, 2007, 61(1): 54-60.
    [23] BEDE O, SURáNYI A, PINTéR K, et al. Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: a randomized, placebo-controlled, double-blind study[J]. Magnes Res, 2003, 16(4): 262-270.
    [24] HILL J, MICKLEWRIGHT A, LEWIS S, et al. Investigation of the effect of short-term change in dietary magnesium intake in asthma[J]. Eur Respir J, 1997, 10(10): 2225-2229.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

罗尧竞,赵小燕,陈莲,胡煜.轻度哮喘持续患儿血清镁水平与症状控制及肺功能关系的研究[J].中国现代医学杂志,2022,(7):84-88

复制
分享
文章指标
  • 点击次数:241
  • 下载次数: 158
  • HTML阅读次数: 28
  • 引用次数: 0
历史
  • 收稿日期:2021-09-21
  • 在线发布日期: 2023-10-30
文章二维码